James Levin, PhD. Senior Director of Preclinical Development, Cidara Therapeutics
Dr. Levin received his Ph.D. in Bacteriology from the University of Maryland, College park, in 1997. During his post-doctoral training he studied the regulation of capsule expression in Streptococcus pyogenes at the Channing Laboratory, Harvard Medical School. Subsequently he has worked on early-stage anti-infectives programs for multiple pharmaceutical companies. These efforts include antimicrobials against both bacterial and viral pathogens using multiple therapeutic approaches (small molecule, immune-based, alternative strategies). Most recently, he has been working on viral respiratory pathogens.
Disclosure: Cidara Therapeutics (Individual(s) Involved: Self): Shareholder